Global Neurotrophins Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 30-Nov-2022
No. of pages: 106
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Neurotrophins manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Neurotrophins market. Further, it explains the major drivers and regional dynamics of the global Neurotrophins market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Johnson?Johnson

- Lonza Groups

- FibroGen

- Scil Proteins GmbH

- Merck Serono

- Scil Proteins GmbH

- PeproTech

- GE Healthcare

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Neurotrophins Segment by Type

- Nerve Growth Factor

- Brain-Derived Neurotrophic Factor

- Dehydroepiandrosterone Sulfate

- Other

Neurotrophins Segment by Application

- Alzheimer'S Disease

- Amyotrophic Lateral Sclerosis

- Parkinson'S Disease

- Other

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Neurotrophins market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Neurotrophins, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Neurotrophins, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Neurotrophins, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurotrophins sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Neurotrophins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Neurotrophins sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Johnson?Johnson, Lonza Groups, FibroGen, Scil Proteins GmbH, Merck Serono, Scil Proteins GmbH, PeproTech and GE Healthcare, etc.

Global Neurotrophins Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Neurotrophins Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Nerve Growth Factor
1.2.3 Brain-Derived Neurotrophic Factor
1.2.4 Dehydroepiandrosterone Sulfate
1.2.5 Other
1.3 Market Segment by Application
1.3.1 Global Neurotrophins Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Alzheimer'S Disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Parkinson'S Disease
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Neurotrophins Market Size (2017-2028)
2.1.1 Global Neurotrophins Revenue (2017-2028)
2.1.2 Global Neurotrophins Sales (2017-2028)
2.2 Global Neurotrophins Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Neurotrophins Sales by Regions (2017-2022)
2.2.2 Global Neurotrophins Revenue by Regions (2017-2022)
2.3 Global Neurotrophins Market Size Forecast by Region
2.3.1 Global Neurotrophins Sales Forecast by Region (2023-2028)
2.3.2 Global Neurotrophins Revenue Forecast by Region (2023-2028)
2.4 Global Top Neurotrophins Regions (Countries) Ranking by Market Size
2.5 Neurotrophins Market Dynamics
2.5.1 Neurotrophins Market Trends
2.5.2 Neurotrophins Market Drivers
2.5.3 Neurotrophins Market Challenges
2.5.4 Neurotrophins Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Neurotrophins Manufacturers by Sales (2017-2022)
3.1.1 Global Neurotrophins Sales by Manufacturers (2017-2022)
3.1.2 Global Neurotrophins Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Neurotrophins Sales in 2021
3.2 Global Top Manufacturers Neurotrophins by Revenue
3.2.1 Global Neurotrophins Revenue by Manufacturers (2017-2022)
3.2.2 Top Neurotrophins Manufacturers Covered: Ranking by Revenue
3.2.3 Global Neurotrophins Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Neurotrophins Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurotrophins as of 2021)
3.4 Global Neurotrophins Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Neurotrophins Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Neurotrophins Market
3.7 Key Manufacturers Neurotrophins Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Neurotrophins Market Size by Type
4.1 Global Neurotrophins Historic Market Review by Type (2017-2022)
4.1.1 Global Neurotrophins Sales Market Share by Type (2017-2022)
4.1.2 Global Neurotrophins Revenue Market Share by Type (2017-2022)
4.1.3 Neurotrophins Price by Type (2017-2022)
4.2 Global Neurotrophins Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Neurotrophins Sales Forecast by Type (2023-2028)
4.2.2 Global Neurotrophins Revenue Forecast by Type (2023-2028)
4.2.3 Neurotrophins Price Forecast by Type (2023-2028)
5 Global Neurotrophins Market Size by Application
5.1 Global Neurotrophins Historic Market Review by Application (2017-2022)
5.1.1 Global Neurotrophins Sales Market Share by Application (2017-2022)
5.1.2 Global Neurotrophins Revenue Market Share by Application (2017-2022)
5.1.3 Neurotrophins Price by Application (2017-2022)
5.2 Global Neurotrophins Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Neurotrophins Sales Forecast by Application (2023-2028)
5.2.2 Global Neurotrophins Revenue Forecast by Application (2023-2028)
5.2.3 Neurotrophins Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neurotrophins Sales Breakdown by Company
6.1.1 North America Neurotrophins Sales by Company (2017-2022)
6.1.2 North America Neurotrophins Revenue by Company (2017-2022)
6.2 North America Neurotrophins Market Size by Type
6.2.1 North America Neurotrophins Sales by Type (2017-2028)
6.2.2 North America Neurotrophins Revenue by Type (2017-2028)
6.3 North America Neurotrophins Market Size by Application
6.3.1 North America Neurotrophins Sales by Application (2017-2028)
6.3.2 North America Neurotrophins Revenue by Application (2017-2028)
6.4 North America Neurotrophins Market Size by Country
6.4.1 North America Neurotrophins Sales by Country (2017-2028)
6.4.2 North America Neurotrophins Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Neurotrophins Sales Breakdown by Company
7.1.1 Europe Neurotrophins Sales by Company (2017-2022)
7.1.2 Europe Neurotrophins Revenue by Company (2017-2022)
7.2 Europe Neurotrophins Market Size by Type
7.2.1 Europe Neurotrophins Sales by Type (2017-2028)
7.2.2 Europe Neurotrophins Revenue by Type (2017-2028)
7.3 Europe Neurotrophins Market Size by Application
7.3.1 Europe Neurotrophins Sales by Application (2017-2028)
7.3.2 Europe Neurotrophins Revenue by Application (2017-2028)
7.4 Europe Neurotrophins Market Size by Country
7.4.1 Europe Neurotrophins Sales by Country (2017-2028)
7.4.2 Europe Neurotrophins Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurotrophins Sales Breakdown by Company
8.1.1 Asia Pacific Neurotrophins Sales by Company (2017-2022)
8.1.2 Asia Pacific Neurotrophins Revenue by Company (2017-2022)
8.2 Asia Pacific Neurotrophins Market Size by Type
8.2.1 Asia Pacific Neurotrophins Sales by Type (2017-2028)
8.2.2 Asia Pacific Neurotrophins Revenue by Type (2017-2028)
8.3 Asia Pacific Neurotrophins Market Size by Application
8.3.1 Asia Pacific Neurotrophins Sales by Application (2017-2028)
8.3.2 Asia Pacific Neurotrophins Revenue by Application (2017-2028)
8.4 Asia Pacific Neurotrophins Market Size by Region
8.4.1 Asia Pacific Neurotrophins Sales by Region
8.4.2 Asia Pacific Neurotrophins Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Neurotrophins Sales Breakdown by Company
9.1.1 Latin America Neurotrophins Sales by Company (2017-2022)
9.1.2 Latin America Neurotrophins Revenue by Company (2017-2022)
9.2 Latin America Neurotrophins Market Size by Type
9.2.1 Latin America Neurotrophins Sales by Type (2017-2028)
9.2.2 Latin America Neurotrophins Revenue by Type (2017-2028)
9.3 Latin America Neurotrophins Market Size by Application
9.3.1 Latin America Neurotrophins Sales by Application (2017-2028)
9.3.2 Latin America Neurotrophins Revenue by Application (2017-2028)
9.4 Latin America Neurotrophins Market Size by Country
9.4.1 Latin America Neurotrophins Sales by Country (2017-2028)
9.4.2 Latin America Neurotrophins Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neurotrophins Sales Breakdown by Company
10.1.1 Middle East and Africa Neurotrophins Sales by Company (2017-2022)
10.1.2 Middle East and Africa Neurotrophins Revenue by Company (2017-2022)
10.2 Middle East and Africa Neurotrophins Market Size by Type
10.2.1 Middle East and Africa Neurotrophins Sales by Type (2017-2028)
10.2.2 Middle East and Africa Neurotrophins Revenue by Type (2017-2028)
10.3 Middle East and Africa Neurotrophins Market Size by Application
10.3.1 Middle East and Africa Neurotrophins Sales by Application (2017-2028)
10.3.2 Middle East and Africa Neurotrophins Revenue by Application (2017-2028)
10.4 Middle East and Africa Neurotrophins Market Size by Country
10.4.1 Middle East and Africa Neurotrophins Sales by Country (2017-2028)
10.4.2 Middle East and Africa Neurotrophins Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Johnson?Johnson
11.1.1 Johnson?Johnson Corporation Information
11.1.2 Johnson?Johnson Overview
11.1.3 Johnson?Johnson Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Johnson?Johnson Neurotrophins Products and Services
11.1.5 Johnson?Johnson Neurotrophins SWOT Analysis
11.1.6 Johnson?Johnson Recent Developments
11.2 Lonza Groups
11.2.1 Lonza Groups Corporation Information
11.2.2 Lonza Groups Overview
11.2.3 Lonza Groups Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Lonza Groups Neurotrophins Products and Services
11.2.5 Lonza Groups Neurotrophins SWOT Analysis
11.2.6 Lonza Groups Recent Developments
11.3 FibroGen
11.3.1 FibroGen Corporation Information
11.3.2 FibroGen Overview
11.3.3 FibroGen Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 FibroGen Neurotrophins Products and Services
11.3.5 FibroGen Neurotrophins SWOT Analysis
11.3.6 FibroGen Recent Developments
11.4 Scil Proteins GmbH
11.4.1 Scil Proteins GmbH Corporation Information
11.4.2 Scil Proteins GmbH Overview
11.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Scil Proteins GmbH Neurotrophins Products and Services
11.4.5 Scil Proteins GmbH Neurotrophins SWOT Analysis
11.4.6 Scil Proteins GmbH Recent Developments
11.5 Merck Serono
11.5.1 Merck Serono Corporation Information
11.5.2 Merck Serono Overview
11.5.3 Merck Serono Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Merck Serono Neurotrophins Products and Services
11.5.5 Merck Serono Neurotrophins SWOT Analysis
11.5.6 Merck Serono Recent Developments
11.6 Scil Proteins GmbH
11.6.1 Scil Proteins GmbH Corporation Information
11.6.2 Scil Proteins GmbH Overview
11.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Scil Proteins GmbH Neurotrophins Products and Services
11.6.5 Scil Proteins GmbH Neurotrophins SWOT Analysis
11.6.6 Scil Proteins GmbH Recent Developments
11.7 PeproTech
11.7.1 PeproTech Corporation Information
11.7.2 PeproTech Overview
11.7.3 PeproTech Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 PeproTech Neurotrophins Products and Services
11.7.5 PeproTech Neurotrophins SWOT Analysis
11.7.6 PeproTech Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Corporation Information
11.8.2 GE Healthcare Overview
11.8.3 GE Healthcare Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 GE Healthcare Neurotrophins Products and Services
11.8.5 GE Healthcare Neurotrophins SWOT Analysis
11.8.6 GE Healthcare Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Neurotrophins Value Chain Analysis
12.2 Neurotrophins Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurotrophins Production Mode & Process
12.4 Neurotrophins Sales and Marketing
12.4.1 Neurotrophins Sales Channels
12.4.2 Neurotrophins Distributors
12.5 Neurotrophins Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Neurotrophins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Nerve Growth Factor
Table 3. Major Manufacturers of Brain-Derived Neurotrophic Factor
Table 4. Major Manufacturers of Dehydroepiandrosterone Sulfate
Table 5. Major Manufacturers of Other
Table 6. Global Neurotrophins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Neurotrophins Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Neurotrophins Sales by Region (2017-2022) & (K Units)
Table 9. Global Neurotrophins Sales Market Share by Region (2017-2022)
Table 10. Global Neurotrophins Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Neurotrophins Revenue Market Share by Region (2017-2022)
Table 12. Global Neurotrophins Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Neurotrophins Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Neurotrophins Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Neurotrophins Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Neurotrophins Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Neurotrophins Market Trends
Table 18. Neurotrophins Market Drivers
Table 19. Neurotrophins Market Challenges
Table 20. Neurotrophins Market Restraints
Table 21. Global Neurotrophins Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Neurotrophins Sales Share by Manufacturers (2017-2022)
Table 23. Global Neurotrophins Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Neurotrophins Manufacturers by Revenue (US$ Million) in 2021
Table 25. Neurotrophins Revenue Share by Manufacturers (2017-2022)
Table 26. Global Neurotrophins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurotrophins as of 2021)
Table 28. Key Manufacturers Neurotrophins Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
Table 29. Key Manufacturers Neurotrophins Plants/Factories Distribution
Table 30. Key Manufacturers Neurotrophins Area Served
Table 31. Date of Key Manufacturers Enter into Neurotrophins Market
Table 32. Key Manufacturers Neurotrophins Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Neurotrophins Sales (K Units) by Type (2017-2022)
Table 35. Global Neurotrophins Sales Share by Type (2017-2022)
Table 36. Global Neurotrophins Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Neurotrophins Price (K Units) by Type (2017-2022)
Table 38. Global Neurotrophins Sales (K Units) by Type (2023-2028)
Table 39. Global Neurotrophins Sales Share by Type (2023-2028)
Table 40. Global Neurotrophins Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Neurotrophins Revenue Share by Type (2023-2028)
Table 42. Global Neurotrophins Price (K Units) by Type (2023-2028)
Table 43. Global Neurotrophins Sales (K Units) by Application (2017-2022)
Table 44. Global Neurotrophins Sales Share by Application (2017-2022)
Table 45. Global Neurotrophins Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Neurotrophins Price (K Units) by Application (2017-2022)
Table 47. Global Neurotrophins Sales (K Units) by Application (2023-2028)
Table 48. Global Neurotrophins Sales Share by Application (2023-2028)
Table 49. Global Neurotrophins Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Neurotrophins Revenue Share by Application (2023-2028)
Table 51. Global Neurotrophins Price (K Units) by Application (2023-2028)
Table 52. North America Neurotrophins Sales by Company (2017-2022) & (K Units)
Table 53. North America Neurotrophins Sales Market Share by Company (2017-2022)
Table 54. North America Neurotrophins Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Neurotrophins Revenue Market Share by Company (2017-2022)
Table 56. North America Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 57. North America Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 58. North America Neurotrophins Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Neurotrophins Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 61. North America Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 62. North America Neurotrophins Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Neurotrophins Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 65. North America Neurotrophins Sales by Country (2023-2028) & (K Units)
Table 66. North America Neurotrophins Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Neurotrophins Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Neurotrophins Sales by Company (2017-2022) & (K Units)
Table 69. Europe Neurotrophins Sales Market Share by Company (2017-2022)
Table 70. Europe Neurotrophins Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Neurotrophins Revenue Market Share by Company (2017-2022)
Table 72. Europe Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 73. Europe Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 74. Europe Neurotrophins Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Neurotrophins Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 77. Europe Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 78. Europe Neurotrophins Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Neurotrophins Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 81. Europe Neurotrophins Sales by Country (2023-2028) & (K Units)
Table 82. Europe Neurotrophins Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Neurotrophins Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Neurotrophins Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Neurotrophins Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Neurotrophins Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Neurotrophins Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Neurotrophins Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Neurotrophins Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Neurotrophins Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Neurotrophins Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Neurotrophins Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Neurotrophins Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Neurotrophins Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Neurotrophins Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Neurotrophins Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Neurotrophins Sales Market Share by Company (2017-2022)
Table 102. Latin America Neurotrophins Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Neurotrophins Revenue Market Share by Company (2017-2022)
Table 104. Latin America Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Neurotrophins Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Neurotrophins Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Neurotrophins Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Neurotrophins Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Neurotrophins Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Neurotrophins Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Neurotrophins Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Neurotrophins Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Neurotrophins Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Neurotrophins Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Neurotrophins Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Neurotrophins Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Neurotrophins Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Neurotrophins Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Neurotrophins Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Neurotrophins Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Neurotrophins Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Neurotrophins Revenue by Country (2023-2028) & (US$ Million)
Table 132. Johnson?Johnson Corporation Information
Table 133. Johnson?Johnson Description and Overview
Table 134. Johnson?Johnson Neurotrophins Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 135. Johnson?Johnson Neurotrophins Product and Services
Table 136. Johnson?Johnson Neurotrophins SWOT Analysis
Table 137. Johnson?Johnson Recent Developments
Table 138. Lonza Groups Corporation Information
Table 139. Lonza Groups Description and Overview
Table 140. Lonza Groups Neurotrophins Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 141. Lonza Groups Neurotrophins Product and Services
Table 142. Lonza Groups Neurotrophins SWOT Analysis
Table 143. Lonza Groups Recent Developments
Table 144. FibroGen Corporation Information
Table 145. FibroGen Description and Overview
Table 146. FibroGen Neurotrophins Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 147. FibroGen Neurotrophins Product and Services
Table 148. FibroGen Neurotrophins SWOT Analysis
Table 149. FibroGen Recent Developments
Table 150. Scil Proteins GmbH Corporation Information
Table 151. Scil Proteins GmbH Description and Overview
Table 152. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 153. Scil Proteins GmbH Neurotrophins Product and Services
Table 154. Scil Proteins GmbH Neurotrophins SWOT Analysis
Table 155. Scil Proteins GmbH Recent Developments
Table 156. Merck Serono Corporation Information
Table 157. Merck Serono Description and Overview
Table 158. Merck Serono Neurotrophins Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 159. Merck Serono Neurotrophins Product and Services
Table 160. Merck Serono Neurotrophins SWOT Analysis
Table 161. Merck Serono Recent Developments
Table 162. Scil Proteins GmbH Corporation Information
Table 163. Scil Proteins GmbH Description and Overview
Table 164. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 165. Scil Proteins GmbH Neurotrophins Product and Services
Table 166. Scil Proteins GmbH Neurotrophins SWOT Analysis
Table 167. Scil Proteins GmbH Recent Developments
Table 168. PeproTech Corporation Information
Table 169. PeproTech Description and Overview
Table 170. PeproTech Neurotrophins Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 171. PeproTech Neurotrophins Product and Services
Table 172. PeproTech Neurotrophins SWOT Analysis
Table 173. PeproTech Recent Developments
Table 174. GE Healthcare Corporation Information
Table 175. GE Healthcare Description and Overview
Table 176. GE Healthcare Neurotrophins Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 177. GE Healthcare Neurotrophins Product and Services
Table 178. GE Healthcare Neurotrophins SWOT Analysis
Table 179. GE Healthcare Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Neurotrophins Distributors List
Table 183. Neurotrophins Customers List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurotrophins Product Picture
Figure 2. Global Neurotrophins Sales Market Share by Type in 2021 & 2028
Figure 3. Nerve Growth Factor Product Picture
Figure 4. Brain-Derived Neurotrophic Factor Product Picture
Figure 5. Dehydroepiandrosterone Sulfate Product Picture
Figure 6. Other Product Picture
Figure 7. Global Neurotrophins Sales Market Share by Application in 2021 & 2028
Figure 8. Alzheimer'S Disease Use Case
Figure 9. Amyotrophic Lateral Sclerosis Use Case
Figure 10. Parkinson'S Disease Use Case
Figure 11. Other Use Case
Figure 12. Neurotrophins Report Years Considered
Figure 13. Global Neurotrophins Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Neurotrophins Market Size 2017-2028 (US$ Million)
Figure 15. Global Neurotrophins Sales (2017-2022) & (K Units)
Figure 16. Global Neurotrophins Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Neurotrophins Sales Market Share by Region (2017-2022)
Figure 18. Global Neurotrophins Sales Market Share by Region in 2021
Figure 19. Global Neurotrophins Revenue Market Share by Region in 2017 VS 2021
Figure 20. Global Neurotrophins Sales Share by Manufacturers in 2021
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Neurotrophins Sales in 2021
Figure 22. Neurotrophins Revenue Share by Manufacturers in 2021
Figure 23. Neurotrophins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 24. Global Neurotrophins Revenue Share by Type (2017-2022)
Figure 25. Global Neurotrophins Revenue Growth Rate by Type in 2017 & 2021
Figure 26. Global Neurotrophins Revenue Share by Application (2017-2022)
Figure 27. Global Neurotrophins Revenue Growth Rate by Application in 2017 & 2021
Figure 28. North America Neurotrophins Sales Market Share by Type (2017-2028)
Figure 29. North America Neurotrophins Revenue Market Share by Type (2017-2028)
Figure 30. North America Neurotrophins Sales Market Share by Application (2017-2028)
Figure 31. North America Neurotrophins Revenue Market Share by Application (2017-2028)
Figure 32. North America Neurotrophins Sales Share by Country (2017-2028)
Figure 33. North America Neurotrophins Revenue Share by Country (2017-2028)
Figure 34. United States Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 35. Canada Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 36. Europe Neurotrophins Sales Market Share by Type (2017-2028)
Figure 37. Europe Neurotrophins Revenue Market Share by Type (2017-2028)
Figure 38. Europe Neurotrophins Sales Market Share by Application (2017-2028)
Figure 39. Europe Neurotrophins Revenue Market Share by Application (2017-2028)
Figure 40. Europe Neurotrophins Sales Share by Country (2017-2028)
Figure 41. Europe Neurotrophins Revenue Share by Country (2017-2028)
Figure 42. Germany Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 43. France Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 44. U.K. Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 45. Italy Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 46. Russia Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 47. Asia Pacific Neurotrophins Sales Market Share by Type (2017-2028)
Figure 48. Asia Pacific Neurotrophins Revenue Market Share by Type (2017-2028)
Figure 49. Asia Pacific Neurotrophins Sales Market Share by Application (2017-2028)
Figure 50. Asia Pacific Neurotrophins Revenue Market Share by Application (2017-2028)
Figure 51. Asia Pacific Neurotrophins Sales Share by Region (2017-2028)
Figure 52. Asia Pacific Neurotrophins Revenue Share by Region (2017-2028)
Figure 53. China Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 54. Japan Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 55. South Korea Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 56. India Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 57. Australia Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 58. China Taiwan Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 59. Indonesia Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 60. Thailand Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 61. Malaysia Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 62. Latin America Neurotrophins Sales Market Share by Type (2017-2028)
Figure 63. Latin America Neurotrophins Revenue Market Share by Type (2017-2028)
Figure 64. Latin America Neurotrophins Sales Market Share by Application (2017-2028)
Figure 65. Latin America Neurotrophins Revenue Market Share by Application (2017-2028)
Figure 66. Latin America Neurotrophins Sales Share by Country (2017-2028)
Figure 67. Latin America Neurotrophins Revenue Share by Country (2017-2028)
Figure 68. Mexico Neurotrophins Revenue (2017-2028) & (US$ Million)
Figure 69. Brazil Neurotrophins Revenue (2017-2028) & (US$
  • Global Atrial Appendage Occluder Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 94
    Highlights The global Atrial Appendage Occluder market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Atrial Appendage Occluder is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 thro......
  • Global Artichoke Extract Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 86
    Highlights The global Artichoke Extract market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Artichoke Extract is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Arteriovenous Fistula Treatment Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 89
    Highlights The global Arteriovenous Fistula Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Arteriovenous Fistula Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 20......
  • Global Antithrombin Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 82
    Highlights The global Antithrombin market was valued at US$ 537.5 million in 2022 and is anticipated to reach US$ 691.6 million by 2029, witnessing a CAGR of 4.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Antithrombin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Anti-Infective Vaccines Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 101
    Highlights The global Anti-Infective Vaccines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Anti-Infective Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through ......
  • Global Alzheimer's Drugs Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Alzheimer's Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Alzheimer's Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Alternative Medicines and Therapy Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 86
    Highlights The global Alternative Medicines and Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Alternative Medicines and Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period o......
  • Global Advance Wound Dressing Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Advance Wound Dressing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Advance Wound Dressing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 20......
  • Global Acromegaly Treatment Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 85
    Highlights The global Acromegaly Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Acromegaly Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs